Kanof, Norman B.

(redirected from Jessner)


Norman B., U.S. physician.
Jessner-Kanof disease - see under Jessner
Jessner-Kanof lesion - Synonym(s): Jessner-Kanof disease
Medical Eponyms © Farlex 2012
References in periodicals archive ?
Fischer founded the company together with Laetitia Jessner in 2018, hoping to make an impact on the environment.
Jessner (Eds.), Cross-linguistic influence in third language acquisition: Psycholinguistic perspectives (pp.
Jessner's lymphocytic skin infiltration is a benign disease in which cutaneous T-lymphocyte infiltration with unknown etiology occurs (1).
Jessner (2008) defined metalinguistic awareness as "the ability to focus on linguistic form, to categorize words into parts of speech, to switch focus between form, function, and meaning, explain why a word has a particular function" (p.
These include an advanced ability in the cognitive process of analysis, advantage in the cognitive process of selective attention and inhibition, and an enhanced ability to learn more languages (Baker 2012; Datta 2000; Edwards 2009; Cummins 2009; and Jessner 2008).
The agents studied in the 11 chemical peel trials included salicylic acid, glycol ic acid, Jessner solution, trichloroacetic acid, mandelic acid, amino fruit acid, and lipohydroxy acids.
There is copious literature, and a journal (Language Awareness) dedicated to exploring this aspect of language learning (Hawkins, 1999; Herdina & Jessner, 2003; Jessner, 2006).
in discoid lupus erythematosus, PN, Behcet's disease, oral aphthosis, pyoderma gangrenosum, actinic prurigo, Jessner's lymphocytic infiltrate, sarcoidosis, and recurrent erythema multiforme.
Her casting came about because Loach and O'Brien had attracted US backers, who insisted on a known American actor for the role of the human rights lawyer Ingrid Jessner, rather than Loach's preferred unknown or non-professional performers.
* Other peeling agents: Pyruvic acid, SA and mandelic acid combinations, phytic acid, Obagi blue peeling and amino fruit acid, light Jessner peeling (2).
Jessner et al., "Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C," Journal of Hepatology, vol.